CEO-TWO
- Product NDC
- 0283-1023
- 11-digit product format
- 002831023
- Labeler code
- 0283
- Product ID
- 0283-1023_42e0774e-b617-290d-e063-6394a90a199e
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Laxative
- Dosage form
- SUPPOSITORY
- Route
- RECTAL
- Labeler
- Beutlich Pharmaceuticals, LLC
- Application
- M007
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2023-10-15
- Substance
- POTASSIUM BITARTRATE; SODIUM BICARBONATE
- Active strength
- .9; .6 g/5.7g; g/5.7g
- Pharmacologic classes
- Alkalinizing Activity [MoA], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- CEO-TWO
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| POTASSIUM BITARTRATE | .9 g/5.7g |
| SODIUM BICARBONATE | .6 g/5.7g |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| NPT6P8P3UU | Internal UNII lookup |
| 8MDF5V39QO | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 08670636-5795-4db0-e063-6294a90afa4b | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0283-1023-00 | CEO-TWO | 5.7 g in 1 DOSE PACK | SUPPOSITORY | 5.7 | 3 | |
| 0283-1023-02 | CEO-TWO | 2 in 1 BOX | SUPPOSITORY | 2 | 3 | |
| 0283-1023-36 | CEO-TWO | 6 in 1 BOX | SUPPOSITORY | 6 | 3 | |
| 0283-1023-54 | CEO-TWO | 54 in 1 BOX | SUPPOSITORY | 54 | 3 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0283-1023-02 | EA - Each | 0283-1023 | d7803fbb-22f6-4acb-bdd2-b3da0cb16667 | 1 | 2025-08-11 |
| 0283-1023-36 | EA - Each | 0283-1023 | 299afce1-70d3-4bcd-88c0-094182298613 | 1 | 2025-08-11 |
| 0283-1023-54 | EA - Each | 0283-1023 | aab567b9-183d-4296-a18e-a6c0a9c6cd3e | 1 | 2025-08-11 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bisacodyl | BISACODYL SUPPOSITORIES | Oncor Pharmaceuticals | 6f0aefc9-cd5f-4bdd-89c2-b6a80558987c | 2025-01-24 | Warnings | M007 |
| Stool Softener Laxative | DOCUSATE SODIUM | NuCare Pharmaceuticals, Inc. | 2c65319f-6cf5-aa90-e063-6394a90ad662 | 2025-01-23 | Warnings | M007 |
| Epsom Salt | MAGNESIUM SULFATE | Cardinal Health (Leader) 70000 | cde87f95-73c0-46f5-9349-37e04096048c | 2025-01-22 | Warnings | M007 |
| Senna-Tabs | SENNA 8.6MG | Ulai Health LLC | 485129a0-8340-4f61-be51-5abff5032b8d | 2025-01-20 | Warnings | M007 |
| Fiber Laxative | CALCIUM POLYCARBOPHIL | Topco Associates, LLC | 0609468d-ee66-49af-be40-e51965b88f6f | 2025-01-20 | Warnings | M007 |
| Soluble Fiber | METHYLCELLULOSE | United Natural Foods, Inc. dba UNFI | 6decd5ef-e8e1-44ae-8465-6266cf18e81e | 2025-01-20 | Warnings | M007 |
| Perdiem | SENNOSIDES, STIMULANT LAXATIVE | Haleon US Holdings LLC | 6b256c8f-3953-4c69-9a16-ffa0511bdbcd | 2025-01-16 | Warnings | M007 |
| Senna Syrup | SENNOSIDES | Everpharm LLC | 0ea9f2b5-4533-4b71-b019-10ecb3c06459 | 2025-01-16 | Warnings | M007 |
| Anecream 5 | LIDOCAINE 5% | Focus Health Group | 1810edc3-093e-402f-bcb0-9c731da283a7 | 2025-01-15 | Warnings | M007 |
| Senna | SENNOSIDES | Reliable 1 Laboratories LLC | ae46a611-20f2-74c8-e053-2995a90a32ce | 2025-01-15 | Warnings | M007 |
| Sennosides and Docusate Sodium | SENNOSIDES, DOCUSATE SODIUM | Reliable-1 Laboratories LLC | a97a1829-f62f-2014-e053-2a95a90a8cc5 | 2025-01-15 | Warnings | M007 |
| Stool Softener Laxative | DOCUSATE SODIUM | NCS HealthCare of KY, LLC dba Vangard Labs | 4d678da0-9ada-4d00-9db9-33b45c776107 | 2025-01-15 | Warnings | M007 |
| Goodsense Fiber laxative 147 | CALCIUM POLYCARBOPHIL | GoodSense | 17f5570b-be85-9dce-e063-6294a90abeaf | 2025-01-14 | Warnings | M007 |
| Sunmark Mineral Oil Laxative | MINERAL OIL | Strategic Sourcing Services | c54f7df2-3845-425f-b13e-3dc000123f3c | 2025-01-14 | Warnings | M007 |
| Senna-S | SENNOSIDES 8.6MG AND DOCUSATE SODIUM 50MG | Ulai Health LLC | c0e27b02-8ef2-4239-8f8c-790f7d978dc0 | 2025-01-12 | Warnings | M007 |
| Docusate Sodium | DOCUSATE SODIUM | Major Pharmaceuticals | 1541ff5b-11f8-444b-a2a0-8e3086ae650a | 2025-01-10 | Warnings | M007 |
| Docusate Sodium | DOCUSATE SODIUM | AvPAK | f31a4349-7826-45c0-9388-6b938d167b7a | 2025-01-09 | Warnings | M007 |
| Docusate sodium | DOCUSATE SODIUM | APNAR PHARMA LP | 05b0732b-012f-78ee-e063-6294a90a839a | 2025-01-09 | Warnings | M007 |
| Foster and Thrive Ready to Use Saline Laxative | SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | McKesson | e5fdfcfd-5340-4929-9f68-2696110cca8e | 2025-01-07 | Warnings | M007 |
| Calcium Polycarbophil | CALCIUM POLYCARBOPHIL | SHANDONG XINHUA PHARMACEUTICAL CO., LTD. | ee06868b-f741-8da2-e053-2a95a90a9772 | 2025-01-02 | Warnings | M007 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 636188 | CEO-TWO 0.9 GM / 0.6 GM Rectal Suppository | PSN | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636185 | potassium bitartrate 0.9 GM / sodium bicarbonate 0.6 GM Rectal Suppository | PSN | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636188 | potassium bitartrate 900 MG / sodium bicarbonate 600 MG Rectal Suppository [Ceo-Two] | SBD | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636185 | potassium bitartrate 900 MG / sodium bicarbonate 600 MG Rectal Suppository | SCD | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636188 | Ceo-Two (potassium bitartrate 0.9 GM / sodium bicarbonate 0.6 GM) Rectal Suppository | SY | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636185 | K+ bitartrate 900 MG / NaHCO3 600 MG Rectal Suppository | SY | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636188 | K+ bitartrate 900 MG / NaHCO3 600 MG Rectal Suppository [Ceo-Two] | SY | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636185 | Pot bitartrate 900 MG / NaHCO3 600 MG Rectal Suppository | SY | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636188 | Pot bitartrate 900 MG / NaHCO3 600 MG Rectal Suppository [Ceo-Two] | SY | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 0283-1023-00 | 00283102300 | 5.7 g in 1 DOSE PACK | 5.7 g | Historical | |||
| 0283-1023-02 | 00283102302 | 2 DOSE PACK in 1 BOX (0283-1023-02) / 5.7 g in 1 DOSE PACK (0283-1023-00) | 2 dose pack | 2023-10-15 | No | No | Current |
| 0283-1023-36 | 00283102336 | 6 DOSE PACK in 1 BOX (0283-1023-36) / 5.7 g in 1 DOSE PACK (0283-1023-00) | 6 dose pack | 2023-10-15 | No | No | Current |
| 0283-1023-54 | 00283102354 | 54 DOSE PACK in 1 BOX (0283-1023-54) / 5.7 g in 1 DOSE PACK (0283-1023-00) | 54 dose pack | 2023-10-15 | No | No | Current |